Spyre Therapeutics, Inc. (SYRE)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

15

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Sep-24 4:04 PM View:	03-Sep-24 Private Sale ($522.07K)	Burrows Scott L Chief Financial Officer		Spyre Therapeutics, Inc. - SYRE	100% 0 to 116.42K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 9:21 PM View:	15-Feb-24 Grant $3.93K	Turtle Cameron Chief Executive Officer Director		Spyre Therapeutics, Inc. - SYRE	3138% 23.07K to 746.91K	0	0	--	--	Show Txns Hide Txns

25-Apr-24 4:55 PM View:	25-Apr-24 Option Exercise 0	Fairmount Funds Management ... Director		Spyre Therapeutics, Inc. - SYRE	1176% 378.42K to 4.83M	0	0	--	--	Show Txns Hide Txns